Drugs / fluorine F18 EF5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01020097 | Mar 2009 → Dec 2013 | squamous cell carcinoma | Abramson Cancer Center at Penn Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluorine F18 EF5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01020097 ↗ |
| Modality | Diagnostic / imaging agent | “fluorine F 18-EF5 positron emission tomography” NCT01020097 ↗ |
| Route | Intravenous | “Given IV” NCT01020097 ↗ |